Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
deals
life sciences
national blog main
2
×
san francisco
san francisco blog main
san francisco top stories
10x genomics
astellas pharma
becton dickinson
cancer
cancer diagnostics
diagnostic device
genetic testing
idiopathic pulmonary fibrosis (ipf)
invitae
lung cancer
lymphoma
medical device
merck
nanostring
new york blog main
non-invasive prenatal tests
prenatal tests
raleigh-durham blog main
san diego blog main
seattle blog main
seattle top stories
singular bio
startups
svb leerink. puneet souda
veracyte
What
deal
expand
2
×
tests
2
×
ability
acquire
adding
aims
array
babies
bio
business
company
cost
decisions
diagnostic
diagnostics
fold
genetic
help
invitae
low
make
maker
medical
nanostring
offers
physicians
prenatal
reach
reached
screen
singular
technology
test
treatment
veracyte
wide
Language
unset
Current search:
photo
×
expand
×
" national blog main "
×
tests
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business